Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
32
pubmed:dateCreated
2005-8-11
pubmed:abstractText
Orexin A and B are neuropeptides implicated in the regulation of sleep/wakefulness and energy homeostasis. The regulatory mechanism of the activity of orexin neurons is not precisely understood. Using transgenic mice in which orexin neurons specifically express yellow cameleon 2.1, we screened for factors that affect the activity of orexin neurons (a total of 21 peptides and six other factors were examined) and found that a sulfated octapeptide form of cholecystokinin (CCK-8S), neurotensin, oxytocin, and vasopressin activate orexin neurons. The mechanisms that underlie CCK-8S-induced activation of orexin neurons were studied by both calcium imaging and slice patch-clamp recording. CCK-8S induced inward current in the orexin neurons. The CCKA receptor antagonist lorglumide inhibited CCK-8S-induced activation of orexin neurons, whereas the CCKB receptor agonists CCK-4 (a tetrapeptide form of cholecystokinin) and nonsulfated CCK-8 had little effect. The CCK-8S-induced increase in intracellular calcium concentration was eliminated by removing extracellular calcium but not by an addition of thapsigargin. Nifedipine, omega-conotoxin, omega-agatoxin, 4-ethylphenylamino-1,2-dimethyl-6-methylaminopyrimidinium chloride, and SNX-482 had little effect, but La3+, Gd3+, and 2-aminoethoxydiphenylborate inhibited CCK-8S-induced calcium influx. Additionally, the CCK-8S-induced inward current was dramatically enhanced in the calcium-free solution and was inhibited by the cation channel blocker SKF96365, suggesting an involvement of extracellular calcium-sensitive cation channels. CCK-8S did not induce an increase in intracellular calcium concentration when membrane potential was clamped at -60 mV, suggesting that the calcium increase is induced by depolarization. The evidence presented here expands our understanding of the regulation of orexin neurons and the physiological role of CCK in the CNS.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/8-sulfocholecystokinin octapeptide, http://linkedlifedata.com/resource/pubmed/chemical/Calcium, http://linkedlifedata.com/resource/pubmed/chemical/Cholecystokinin, http://linkedlifedata.com/resource/pubmed/chemical/Intracellular Signaling Peptides..., http://linkedlifedata.com/resource/pubmed/chemical/Luminescent Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Neuropeptides, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Cholecystokinin A, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, G-Protein-Coupled, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Neuropeptide, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Fusion Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Sincalide, http://linkedlifedata.com/resource/pubmed/chemical/Ycam-2 flourescent protein, http://linkedlifedata.com/resource/pubmed/chemical/orexin receptors, http://linkedlifedata.com/resource/pubmed/chemical/orexins
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1529-2401
pubmed:author
pubmed:issnType
Electronic
pubmed:day
10
pubmed:volume
25
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
7459-69
pubmed:dateRevised
2011-8-1
pubmed:meshHeading
pubmed-meshheading:16093397-Animals, pubmed-meshheading:16093397-Calcium, pubmed-meshheading:16093397-Cholecystokinin, pubmed-meshheading:16093397-Electric Conductivity, pubmed-meshheading:16093397-Excitatory Postsynaptic Potentials, pubmed-meshheading:16093397-Extracellular Fluid, pubmed-meshheading:16093397-Female, pubmed-meshheading:16093397-Fluorescent Antibody Technique, pubmed-meshheading:16093397-Intracellular Signaling Peptides and Proteins, pubmed-meshheading:16093397-Luminescent Proteins, pubmed-meshheading:16093397-Male, pubmed-meshheading:16093397-Mice, pubmed-meshheading:16093397-Mice, Transgenic, pubmed-meshheading:16093397-Neural Inhibition, pubmed-meshheading:16093397-Neurons, pubmed-meshheading:16093397-Neuropeptides, pubmed-meshheading:16093397-Patch-Clamp Techniques, pubmed-meshheading:16093397-Receptor, Cholecystokinin A, pubmed-meshheading:16093397-Receptors, G-Protein-Coupled, pubmed-meshheading:16093397-Receptors, Neuropeptide, pubmed-meshheading:16093397-Recombinant Fusion Proteins, pubmed-meshheading:16093397-Recombinant Proteins, pubmed-meshheading:16093397-Sincalide, pubmed-meshheading:16093397-Synaptic Transmission
pubmed:year
2005
pubmed:articleTitle
Cholecystokinin activates orexin/hypocretin neurons through the cholecystokinin A receptor.
pubmed:affiliation
Department of Molecular Pharmacology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan.
pubmed:publicationType
Journal Article, In Vitro, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural